Mustafa Bulut MD , Fatma Betul Celik MD , Tolga Sinan Guvenc MD , Yusuf Yilmaz MD , Mehmet Celik MD , Serhan Ozyildirim MD , Kemal Gocer MD , Murat Asik MD , Seref Kul MD , Mustafa Caliskan MD
{"title":"甘油三酯-葡萄糖指数和稳态模型评估对预测冠状动脉微血管功能障碍的作用","authors":"Mustafa Bulut MD , Fatma Betul Celik MD , Tolga Sinan Guvenc MD , Yusuf Yilmaz MD , Mehmet Celik MD , Serhan Ozyildirim MD , Kemal Gocer MD , Murat Asik MD , Seref Kul MD , Mustafa Caliskan MD","doi":"10.1016/j.jacl.2024.04.135","DOIUrl":null,"url":null,"abstract":"<div><h3>BACKGROUND</h3><div>Coronary microvascular dysfunction (CMD) is a common occurrence in individuals with insulin resistance (IR). Homeostatic model assessment for insulin resistance (HOMA-IR) is a widely used surrogate marker of IR, although recent studies suggest triglyceride-glucose (TyG) index is a superior marker of IR that had a better accuracy to predict type 2 diabetes or cardiovascular outcomes than HOMA-IR.</div></div><div><h3>OBJECTIVES</h3><div>We aimed to assess the accuracy and usefulness of TyG index and HOMA-IR for predicting CMD as assessed with echocardiographic coronary flow reserve (CFR) measurement.</div></div><div><h3>METHODS</h3><div>All cases included in the institutional CFR registry were retrospectively reviewed, and 656 cases without epicardial coronary artery disease and without major risk factors for atherosclerosis were included. A CFR ≤2.0 was defined as CMD.</div></div><div><h3>RESULTS</h3><div>TyG index was available in all cases, while HOMA-IR was available in 398 cases. Both TyG index and HOMA-IR were associated with CMD on univariate analyses, while after adjustment for potential confounders HOMA-IR (odds ratio [OR]:1.38, 95% confidence interval [CI]:1.14–1.67, <em>p</em> = 0.001) but not TyG index (OR:1.48, 95% CI:0.82–2.67, <em>p</em> = 0.19) was associated with CMD. The predictive accuracy of HOMA-IR (c-statistic:0.63, 95% CI:0.54–0.72, <em>p</em> = 0.003) was higher than TyG index(c-statistic:0.55, 95% CI:0.47–0.63, <em>p</em> = 0.13), although the difference was not statistically significant (DeLong <em>p</em> = 0.23). There was strong evidence favoring a true difference between CMD vs. non-CMD groups for HOMA-IR (BF<sub>10</sub>:3507) but not for TyG index(BF<sub>10</sub>:0.66).</div></div><div><h3>CONCLUSIONS</h3><div>HOMA-IR, but not TyG index, is closely associated with CMD.</div></div>","PeriodicalId":15392,"journal":{"name":"Journal of clinical lipidology","volume":"18 5","pages":"Pages e764-e772"},"PeriodicalIF":3.6000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Usefulness of triglyceride-glucose index and homeostatic model assessment for predicting coronary microvascular dysfunction\",\"authors\":\"Mustafa Bulut MD , Fatma Betul Celik MD , Tolga Sinan Guvenc MD , Yusuf Yilmaz MD , Mehmet Celik MD , Serhan Ozyildirim MD , Kemal Gocer MD , Murat Asik MD , Seref Kul MD , Mustafa Caliskan MD\",\"doi\":\"10.1016/j.jacl.2024.04.135\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>BACKGROUND</h3><div>Coronary microvascular dysfunction (CMD) is a common occurrence in individuals with insulin resistance (IR). Homeostatic model assessment for insulin resistance (HOMA-IR) is a widely used surrogate marker of IR, although recent studies suggest triglyceride-glucose (TyG) index is a superior marker of IR that had a better accuracy to predict type 2 diabetes or cardiovascular outcomes than HOMA-IR.</div></div><div><h3>OBJECTIVES</h3><div>We aimed to assess the accuracy and usefulness of TyG index and HOMA-IR for predicting CMD as assessed with echocardiographic coronary flow reserve (CFR) measurement.</div></div><div><h3>METHODS</h3><div>All cases included in the institutional CFR registry were retrospectively reviewed, and 656 cases without epicardial coronary artery disease and without major risk factors for atherosclerosis were included. A CFR ≤2.0 was defined as CMD.</div></div><div><h3>RESULTS</h3><div>TyG index was available in all cases, while HOMA-IR was available in 398 cases. Both TyG index and HOMA-IR were associated with CMD on univariate analyses, while after adjustment for potential confounders HOMA-IR (odds ratio [OR]:1.38, 95% confidence interval [CI]:1.14–1.67, <em>p</em> = 0.001) but not TyG index (OR:1.48, 95% CI:0.82–2.67, <em>p</em> = 0.19) was associated with CMD. The predictive accuracy of HOMA-IR (c-statistic:0.63, 95% CI:0.54–0.72, <em>p</em> = 0.003) was higher than TyG index(c-statistic:0.55, 95% CI:0.47–0.63, <em>p</em> = 0.13), although the difference was not statistically significant (DeLong <em>p</em> = 0.23). There was strong evidence favoring a true difference between CMD vs. non-CMD groups for HOMA-IR (BF<sub>10</sub>:3507) but not for TyG index(BF<sub>10</sub>:0.66).</div></div><div><h3>CONCLUSIONS</h3><div>HOMA-IR, but not TyG index, is closely associated with CMD.</div></div>\",\"PeriodicalId\":15392,\"journal\":{\"name\":\"Journal of clinical lipidology\",\"volume\":\"18 5\",\"pages\":\"Pages e764-e772\"},\"PeriodicalIF\":3.6000,\"publicationDate\":\"2024-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of clinical lipidology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1933287424001831\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of clinical lipidology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1933287424001831","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
Usefulness of triglyceride-glucose index and homeostatic model assessment for predicting coronary microvascular dysfunction
BACKGROUND
Coronary microvascular dysfunction (CMD) is a common occurrence in individuals with insulin resistance (IR). Homeostatic model assessment for insulin resistance (HOMA-IR) is a widely used surrogate marker of IR, although recent studies suggest triglyceride-glucose (TyG) index is a superior marker of IR that had a better accuracy to predict type 2 diabetes or cardiovascular outcomes than HOMA-IR.
OBJECTIVES
We aimed to assess the accuracy and usefulness of TyG index and HOMA-IR for predicting CMD as assessed with echocardiographic coronary flow reserve (CFR) measurement.
METHODS
All cases included in the institutional CFR registry were retrospectively reviewed, and 656 cases without epicardial coronary artery disease and without major risk factors for atherosclerosis were included. A CFR ≤2.0 was defined as CMD.
RESULTS
TyG index was available in all cases, while HOMA-IR was available in 398 cases. Both TyG index and HOMA-IR were associated with CMD on univariate analyses, while after adjustment for potential confounders HOMA-IR (odds ratio [OR]:1.38, 95% confidence interval [CI]:1.14–1.67, p = 0.001) but not TyG index (OR:1.48, 95% CI:0.82–2.67, p = 0.19) was associated with CMD. The predictive accuracy of HOMA-IR (c-statistic:0.63, 95% CI:0.54–0.72, p = 0.003) was higher than TyG index(c-statistic:0.55, 95% CI:0.47–0.63, p = 0.13), although the difference was not statistically significant (DeLong p = 0.23). There was strong evidence favoring a true difference between CMD vs. non-CMD groups for HOMA-IR (BF10:3507) but not for TyG index(BF10:0.66).
CONCLUSIONS
HOMA-IR, but not TyG index, is closely associated with CMD.
期刊介绍:
Because the scope of clinical lipidology is broad, the topics addressed by the Journal are equally diverse. Typical articles explore lipidology as it is practiced in the treatment setting, recent developments in pharmacological research, reports of treatment and trials, case studies, the impact of lifestyle modification, and similar academic material of interest to the practitioner. While preference is given to material of immediate practical concern, the science that underpins lipidology is forwarded by expert contributors so that evidence-based approaches to reducing cardiovascular and coronary heart disease can be made immediately available to our readers. Sections of the Journal will address pioneering studies and the clinicians who conduct them, case studies, ethical standards and conduct, professional guidance such as ATP and NCEP, editorial commentary, letters from readers, National Lipid Association (NLA) news and upcoming event information, as well as abstracts from the NLA annual scientific sessions and the scientific forums held by its chapters, when appropriate.